Skip to content

A Study Of The Effect Of Nalbuphine Preempative Analgesia In Laparoscopic Total Hysterectomy

A Study Of The Effect Of Nalbuphine Preempative Analgesia In Laparoscopic Total Hysterectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089664
Enrollment
Unknown
Registered
2024-09-12
Start date
2024-09-12
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia after laparoscopic total hysterectomy

Interventions

Group nalbuphine:Nalbuphine 0.2 mg/kg given before induction of anesthesia
Group sufentanil:Sufentanil 0.2 ug/kg given before induction of anesthesia

Sponsors

The Second Affiliated Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 49 Years

Inclusion criteria

Inclusion criteria: ?American Society of Anesthesiologists (ASA) class ?~?; ?Surgical indications for laparoscopic total hysterectomy; ?Age: 40~49 years old; ?Estimated duration of surgery <3h; ?Patient's pain sensitivity score 4~6; ?Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: ? emergency surgery; ? combined with serious cardiac, hepatic and renal dysfunction; ? preoperative application of other analgesic and sedative, antiemetic, anti-inflammatory drugs; ? combined with a history of smoking, alcohol consumption; ? combined with clinical factors affecting nociception, such as diabetes mellitus; ? severe OSAHS and obese patients (BMI = 30kg/m2); ? combined with psychiatric system diseases

Design outcomes

Primary

MeasureTime frame
postoperative visceral pain;postoperative body pain;

Secondary

MeasureTime frame
Incidence of postoperative adverse reactions;Incidence of myoclonus during induction of anesthesia;Incidence of choking during induction of anesthesia;

Countries

China

Contacts

Public ContactWensheng Zhang

The Second Affiliated Hospital of Shandong First Medical University

zhwsh1968@sina.com+86 185 0538 6976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026